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Introduction to thesis 
 
Dysfunctional breathing (DB) has been long recognised as a condition affecting 
numerous people and influencing a range of health disorders. In the past, DB has 
been recognised as involving only hyperventilation syndrome with the presence of 
hypocapnia (Courtney & Greenwood, 2009; M. Thomas, McKinley, Freeman, & Foy, 
2001; van Dixhoorn & Duivenvoorden, 1985). More recently it has been 
acknowledged that signs and symptoms of DB can occur with abnormal breathing 
patterns in the absence of hypocapnia (Burton, 1993; Courtney & Cohen, 2008; 
Hornsveld & Garsson, 1997). The recent acknowledgment, that DB may occur in the 
absence of hypocapnia, has sparked recent research that leads towards a new 
definition of DB and the development of valid and reliable diagnostic measures. The 
Self Evaluation of Breathing Questionnaire (SEBQ) has been recently developed by 
Courtney and co-workers (2009). It is a self-report questionnaire, which has been 
formulated in an attempt to more comprehensively recognise signs and symptoms of 
DB. Self-report measures have the potential to be useful in clinical contexts and may 
assist with diagnosis and management of DB. 
This thesis is arranged in three main sections:  Section 1 is a literature review that 
outlines normal breathing mechanics and breathing dysfunction; examines the 
validity and clinical utility of currently used diagnostic and assessment tools for 
varying breathing conditions; and reviews the variables associated or potentially 
associated with DB. Section 2 of the thesis contains a manuscript formatted for 
submission to the journal Physiotherapy. Section 3 (appendices) contains other 
material supplementary to the thesis. The aim of the study reported in this 
manuscript was to determine the test-retest reliability of the SEBQ and to investigate 
lifestyle or demographic variables that may be potentially associated with, or predict, 
SEBQ scores. 
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1. Introduction 
 
Dysfunctional breathing (DB) is not currently well defined, but is a term that has 
recently been applied to a range of signs and symptoms that often occur together 
and may have a range of underlying causes.  Classically, DB was only recognised to 
involve hyperventilation syndrome with the presence of hypocapnia (Courtney & 
Greenwood, 2009; M. Thomas et al., 2001; van Dixhoorn & Duivenvoorden, 1985). It 
has recently been acknowledged that DB signs and symptoms may occur with 
abnormal breathing patterns in the absence of hypocapnia (Burton, 1993; Courtney 
& Cohen, 2008; Hornsveld & Garsson, 1997).  Courtney (2009) describes DB as 
“breathing which is unable to perform its various functions efficiently and is 
inappropriate for the needs of the individual at that time”.  Dysfunctional breathing 
is thought to have several contributing causative factors including biomechanical, 
biochemical and psychophysiological influences (Courtney, van Dixhoorn, 
Greenwood, & Anthonissen, 2011).  It has been acknowledged that DB may occur as 
a functional problem in healthy individuals and may include hyperventilation, poor 
breathing control, breathing pattern abnormalities and presence of breathing 
symptoms (Courtney, Greenwood, & Cohen, 2011; Warburton & Jack, 2006). 
Dysfunctional breathing may also occur in people with diagnosed ‘pathology’ or 
respiratory conditions such as asthma. The diagnosed condition may be the primary 
cause of DB and DB may exacerbate symptoms of the underlying condition (M. 
Thomas, 2003).  Dysfunctional breathing is thought to exaggerate the symptoms of a 
wide range of conditions treated commonly by healthcare practitioners.  Some of 
these conditions include: asthma (Stanton, Vaughn, Carter, & Bucknall, 2008; M. 
Thomas et al., 2001; M. Thomas et al., 2003), chronic fatigue (Chaitow, 2007), 
cardiovascular symptoms (Courtney, Cohen, & van Dixhoorn, 2011; Courtney, van 
Dixhoorn, et al., 2011), myofascial pain syndromes (Bartley, 2011; Chaitow, 2007; 
Courtney, 2009), temporomandibular joint disorders (Bartley, 2011), altered spinal 
stability; and, headaches and migraines (Bartley, 2011; Courtney, 2009).   
Due to the recent acknowledgment that DB is more complex than implied by earlier 
definitions, there is currently no criterion measure for it.   A new diagnostic tool that 
is sensitive to the effects of both classical and non-classical forms of DB may be 
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beneficial in a clinical setting for the detection and management of DB.   The Self 
Evaluation of Breathing Questionnaire (SEBQ) has been recently developed by 
Courtney & Greenwood (2009) to be a clinically applicable, self-report questionnaire 
that attempts to comprehensively cover signs and symptoms of DB.   The SEBQ items 
have been developed from a wide variety of sources with the aim of including the 
broader range of DB symptoms that have now been acknowledged (Courtney & 
Greenwood, 2009). 
This review explores the mechanisms of breathing, its various forms of dysfunction 
and how they may influence health conditions treated in routine clinical practice.  
The review also describes and critically evaluates the currently available diagnostic 
tools for the assessment of different forms of breathing dysfunction.   Finally, the 
review considers variables associated, or potentially associated, with DB. 
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2. Breathing Mechanics 
 
 
When the respiratory system is functioning normally, in a resting state, breathing 
should occur with a low perceived effort and at a frequency between 12 and 15 
breaths/minute (Richardson, 2006).  During ‘ideal’ inspiration, the diaphragm 
descends and the abdominal wall and lower intercostal muscles stretch passively 
(Chaitow, Bradley, & Gilbert, 2002, pp. 15-18; Richardson, 2006).   Diaphragm and 
lower chest wall excursion can be measured during deep breathing and is typically 
between 4 to 7cm in healthy individuals (Wang et al., 2009).   The diaphragm is often 
described as ‘the primary muscle of inspiration’ and provides an essential pumping 
action which is vital for numerous body functions, including homeostasis of thoracic 
and abdominal pressures, mobility and motility of organs, and lymphatic and 
cardiovascular pump movement (Bacchus, 2010; Bartley & Clifton-Smith, 2006, p. 56; 
West, 2000, p. 2).   In the resting state, expiration occurs through elastic recoil of the 
lungs and the upper chest and accessory muscles of breathing including upper 
trapezius, intercostals, sternocleidomastoid, pectoralis muscles and scalenes should 
remain relaxed (Chaitow et al., 2002, pp. 15-18; Gilbert, 1998; Richardson, 2006; 
Schuenke, Schulte, & Schumacher, 2006, pp. 132, 258, 268).   
The primary purposes of respiration are for gas exchange and homeostatic 
maintenance of pH balance within the body (Bacchus, 2010; Bartley, 2011; West, 
2000, pp. 10-22).   When inspiration occurs, air is inhaled and eventually oxygen is 
transferred into cells where it acts as a fuel to generate energy for all body functions 
(West, 2000, p. 17).  During this process carbon dioxide is removed as a by-product 
of the energy-generating reactions.   Carbon dioxide is then transported, from the 
cells by the blood and eventually back to the lungs where it is expelled into the 
atmosphere (Bartley & Clifton-Smith, 2006, pp. 40-44; West, 2000, p. 17).   Acidity 
and alkalinity of blood is determined by the partial pressure of carbon dioxide (pCO2) 
and the concentration of bicarbonate molecules in the blood (Bacchus, 2010; Bartley, 
2011; West, 2000, pp. 19-22).   In a normally functioning system the pH of the 
human body should be relatively neutral, equalling 7.4; disturbances in the acid-base 
balance may result in either respiratory or metabolic alkalosis or acidosis (West, 
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2000, pp. 19-22).   Respiratory alkalosis occurs when there is a increased arterial 
partial pressure of oxygen (pO2) and decreased pCO2, thus elevating the pH, this 
arises in a state of hyperventilation with hypocapnia (West, 2000, pp. 19-22).  
Respiratory acidosis may occur in hypoventilation leading to a decrease in pO2 and 
subsequently an increase in pCO2 resulting in hypoxia and a lowered pH level (West, 
2000, pp. 19-22).   The concentration of oxygen in the alveolar compartments of the 
lungs is determined by a balance between the rate of removal of oxygen from the 
lungs into the blood (known as perfusion) and the rate of replenishment of oxygen 
into the lungs (known as ventilation) (West, 2000, pp. 46-47).  Therefore, in an 
ideally functioning respiratory system, ventilation and perfusion of lung tissues 
should be matched for efficient gas exchange (Hansen, Ulubay, Chow, Sun, & 
Wasserman, 2007).   Oxygen is vital for all processes that occur within the body.  
Carbon dioxide is an important determinant of acid-base balance, it assists in the 
dissociation of oxygen from haemoglobin, the control of cerebral blood flow and 
neuronal excitability, and constriction of blood vessels and muscular contraction 
(Bartley & Clifton-Smith, 2006; Courtney, 2009).   
3. Dysfunctional Breathing  
 
 
Dysfunctional breathing is not currently well defined, but is a term used to describe a 
complex phenomenon which is thought to have several contributing causative 
factors including biomechanical, biochemical and psychophysiological influences 
(Courtney, van Dixhoorn, et al., 2011).   Various forms of DB have been recently 
acknowledged.  These include the classical form of DB known as hyperventilation 
syndrome, and recently recognised forms such as  poor breathing control, breathing 
pattern abnormalities and presence of unexplained breathing symptoms (Courtney, 
Greenwood, et al., 2011; Warburton & Jack, 2006).   It has been acknowledged that 
DB may occur as a functional problem in healthy individuals resulting in unexplained 
breathing complaints (Courtney, van Dixhoorn, et al., 2011).  Dysfunctional breathing 
may also occur in people with diagnosed pathology or respiratory conditions.  The 
diagnosed condition may be the primary cause of DB which may exacerbate 
symptoms of the underlying condition (M. Thomas, 2003).   Several previous studies 
 
 
14 
 
support the hypothesis that people with DB may benefit from breathing retraining 
programmes (Chaitow, 2007; Gilbert, 2003; Hagman, Janson, & Emtner, 2011; M. 
Thomas et al., 2003). 
3.1. Hyperventilation Syndrome 
Dysfunctional Breathing was originally thought to occur only during hyperventilation 
syndrome with the presence of hypocapnia (Courtney & Greenwood, 2009; M. 
Thomas et al., 2001; van Dixhoorn & Duivenvoorden, 1985).   Hyperventilation 
occurs when respiratory rate is increased, leading to the rate of ventilation being 
greater than the rate of perfusion, and the metabolic requirement for oxygen being 
exceeded, thus resulting in higher oxygen levels within the lungs (Bartley, 2011; 
Schleifer, Ley, & Spalding, 2002; West, 2000, pp. 18-20).   During hyperventilation 
arterial carbon dioxide levels are lowered as excess carbon dioxide is expelled into 
the air during the over breathing process (Bartley, 2011; Schleifer et al., 2002).  
Clinically the term hyperventilation is used to describe two main clinical syndromes: 
the first syndrome is acute episodic hyperventilation which occurs in scenarios such 
as a ‘panic attack’ (Warburton & Jack, 2006).  The second form of hyperventilation 
syndrome is chronic hyperventilation which commonly occurs in people with 
significant anxiety problems (Warburton & Jack, 2006).   In both chronic and acute 
hyperventilation syndrome, arterial carbon dioxide levels are lowered resulting in 
increasing alkalosis and symptoms such as breathlessness, sensations of chest 
tightness, and feelings of parasthesia in fingers or toes (van Dixhoorn & 
Duivenvoorden, 1985; Warburton & Jack, 2006).   Hyperventilation syndrome has 
been recognised for many years as the main form of DB, therefore, the Nijmegen 
Questionnaire has been developed and validated for the measurement of 
hyperventilation syndrome (van Dixhoorn & Duivenvoorden, 1985; van Doorn, 
Folgering, & Colla, 1982).   Currently there is no validated tool for the recognition of 
the broader forms of DB that have now been acknowledged. 
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 3.2. Non-classical Dysfunctional Breathing 
It has now been observed that DB-related symptoms such as breathlessness, 
tightness in the chest, inability to breathe deeply, and fast breathing can occur with 
abnormal breathing patterns when carbon dioxide levels remain normal within the 
body (Courtney & Cohen, 2008; Hornsveld & Garsson, 1997).   The diagnosis of DB is 
currently made on the basis of symptoms, breathing patterns, and sometimes, but 
not always, the measurable presence of hyperventilation and hypocapnia (Courtney 
& Cohen, 2008; Courtney, Greenwood, et al., 2011).   Signs of DB include asynchrony 
of breathing movement between thorax and abdomen, upper thoracic breathing, 
frequent or deep sighs, mouth breathing in low oxygen demand situations, and 
exaggerated use of accessory muscles of breathing (Bartley & Clifton-Smith, 2006, pp. 
57-65; Chaitow et al., 2002, p. 2; Courtney & Greenwood, 2009).   The most 
recognisable DB patterns include asynchronous and paradoxical motion between the 
ribcage and abdomen, lateral or upper chest breathing (Bartley & Clifton-Smith, 
2006; Courtney, 2009).   With any of these patterns the mechanics of the diaphragm 
and thorax will vary from normal physiological patterns and may result in symptoms 
of DB (Courtney, 2009).  Some DB-related symptoms that have been reported 
include: changes to breathing sensations, sighing, yawning, periods of breath holding, 
and mouth breathing (Courtney & Greenwood, 2009).   If diaphragm function is 
altered from its normal pattern there may be several effects on the body (Courtney, 
2009). 
3.3. Effects of Dysfunctional Breathing 
If the diaphragm is not functioning ideally and the ‘respiratory pump’ is impaired 
there may be several effects.  The accessory muscles of breathing including the 
upper trapezius, intercostals, sternocleidomastoid, pectoralis muscles and scalenes 
increase their activity, which can lead to postural changes of the trunk, head and 
shoulder girdle such as ‘upper crossed syndrome’ (Courtney, 2009; Moore, 2004).  
‘Upper cross syndrome’ was first attributed to Janda (Liebenson, 2007, p. 40) and is 
described as tightness in the upper trapezius, pectoralis, sternocleidomastoid and 
levator scapulae muscles with weakness in rhomboids, serratus anterior, lower 
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trapezius and deep neck flexors (Liebenson, 2007, pp. 40-42; Moore, 2004).   These 
muscular changes lead to characteristic elevation and protraction of the shoulder 
girdles, winging of the scapula, and a forward head posture (Moore, 2004).   Other 
postural changes such as flattened spinal curvatures, and altered balance may also 
occur in DB due to the alteration in costal and spinal mechanics and muscular tone in 
the accessory muscles of breathing.   Postural changes are considered to contribute 
to, and aggravate, numerous conditions including temporomandibular joint pain 
(Bartley, 2011), shoulder, neck, thorax, and lower back pain (Chaitow, 2007; 
Courtney, 2009); and headaches (Courtney, 2009; Hruska, 1997).   
Alterations in the respiratory pump may lead to adjustments in rhythmic pressure 
fluctuations between thoracic and abdominal cavities (Courtney, 2009).   In normal 
respiration there is a decrease in intra-thoracic pressure during inspiration, and an 
increase in intra-abdominal pressure during expiration (Courtney, 2009; DeBoer, 
Karemaker, & Strakee, 1987).   Changes of intra-chest cavity pressures may occur 
with abnormal breathing patterns, and are thought to lead to hemodynamic and 
lymphatic pump rhythm changes (Courtney, 2009).   The change in the lymphatic 
pump has been proposed to alter the lymphatic system’s ability to filter cell debris, 
pathogens and cancer cells and decrease its ability to initiate a immune response to 
them, exacerbating illness and impairing normal healing ability (Courtney, 2009).  
However, direct evidence of these effects have not been directly linked to DB.  
Disease states that are thought to be exaggerated by DB include chronic pain 
syndromes (Chaitow, 2007), hypertension (Courtney, Cohen, et al., 2011), asthma 
(Hagman et al., 2011; M. Thomas, 2003; M. Thomas et al., 2001), anxiety, and 
depression (Gilbert, 2003), most of which have been seen to be improved by 
breathing retraining. 
3.4. Breathing Retraining  
Breathing retraining may involve a practitioner providing education about ideal 
breathing, and breathing exercises to a patient with the aim of improving 
physiological function of breathing mechanics.  There are at least two specific 
methods for breathing retraining including the Papworth method (Holloway & West, 
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2007) and the Buteyko Breathing Method (S. Thomas, 2004).  Breathing retraining 
can also be performed as an individualised programme where a practitioner chooses 
specific exercises dependent on the needs of the patient at the time (Hagman et al., 
2011; M. Thomas et al., 2003).   
The Papworth method was developed in the 1960s and has mainly been used for 
retraining breathing in people suffering from hyperventilation syndrome (Holloway 
& West, 2007).  The method involves educating patients about hyperventilation, 
ideal breathing, and recognition and management of stress.  Patients are then shown 
and asked to perform diaphragmatic and nasal breathing exercises, and undertake 
relaxation techniques in different positions (Holloway & West, 2007).   Halloway and 
West (2007) published a randomised controlled trial examining the effects of the 
Papworth method on quality of life and symptoms of asthmatics.   This study 
randomly allocated 85 participants into a control or intervention group.  The control 
group received no additional treatment for their asthma than what they were 
receiving prior to the study.  The intervention group each received five breathing and 
relaxation training sessions with a respiratory physiotherapist using the Papworth 
method.  The authors of the study reported that after both six and 12 month follow-
ups the intervention group had improved their respiratory symptoms and health-
related quality of life compared to the control group (Holloway & West, 2007).  
Although not reported by the authors, the magnitudes of the effects were ‘moderate’ 
for both respiratory symptoms and health related quality of life.  No significant 
change was found in measures of lung function and this may suggest that breathing 
and relaxation training is not affecting the underlying pathology associated with 
asthma, but the symptoms and quality of life resulting from manifestations of 
dysfunctional breathing (Holloway & West, 2007). 
The Buteyko Breathing Method was originally developed in the 1950s (Bruton & 
Lewith, 2005).  Buteyko claimed that the breathing technique applied corrects 
chronic hyperventilation by raising arterial carbon dioxide levels (Courtney, 2008; 
Courtney & Cohen, 2008; S. Thomas, 2004).   The Buteyko Breathing Method 
recommends five hours contact time with a trained Buteyko practitioner where 
exercises are given in an aim to decrease ventilation.  Ventilation is decreased either 
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through slowing the breathing rate of the patient or reducing tidal volume of oxygen 
by adding pauses to breathing after expiration (S. Thomas, 2004).   In a review of 
literature on the Buteyko method, Thomas (2004) concludes that there have been 
four trials investigating the effectiveness of the method for asthmatics (Bowler, 
Green, & Mitchell, 1998; Cooper et al., 2003; McHugh, Aitcheson, Duncan, & 
Houghton, 2003; Opat, Cohen, Bailey, & Abramson, 2000).   All four of these studies 
concluded that the Buteyko method is effective in reducing the frequency of use of 
bronchodilators in patients with asthma (Bowler et al., 1998; Cooper et al., 2003; 
McHugh et al., 2003; Opat et al., 2000).   A difficulty in investigating the physiological 
effects of the Buteyko method on medication use is that the Buteyko method 
actively encourages a decreased use of asthma medication.   Practitioners instruct 
patients to use their medication only when absolutely necessary (M. Thomas et al., 
2003; S. Thomas, 2004).   Due to the active encouragement in the Buteyko method 
to decrease medication use, frequency of bronchodilator use in participants may not 
be an accurate measure of the efficacy of the technique and further investigations 
into the efficacy and effectiveness of the Buteyko method are required. 
Individualised breathing retraining programmes have been shown to improve quality 
of life in people with breathing complaints in at least two studies (Hagman et al., 
2011; M. Thomas et al., 2003).   Thomas, et al.  (2003) performed a randomised 
controlled trial on 33 adult participants with both currently diagnosed and managed 
asthma, and diagnosed DB as identified using the Nijmegen Questionnaire for 
hyperventilation syndrome.   Participants were split into two groups.   The first 
received three individualised breathing retraining sessions with a physiotherapist 
over a 3-week period, and the second group received a one off asthma education 
session with an asthma nurse (M. Thomas et al., 2003).   Authors reported that 
statistically significant and clinically meaningful improvements in quality of life 
scores (Asthma Quality of Life Questionnaire) were found at a one-month follow-up 
compared to those who did not receive the retraining (M. Thomas et al., 2003).   At 
six month follow-up those who received the breathing retraining retained their 
improvements (M. Thomas et al., 2003).   
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A recent case-control study examined the long-term effects of breathing retraining in 
participants with diagnosed breathing dysfunction (Hagman et al., 2011).   The study 
included two participant groups.   The first group included 25 participants who were 
diagnosed with DB by clinical observation of breathing pattern, and on the basis of 
DB symptoms (Hagman et al., 2011).   To be diagnosed with DB, participants were 
required to have at least 5 out of 10 of the following symptoms: 1) difficulty on 
inspiration; 2) inability to take deep breaths; 3) increased respiratory rate; 4) 
frequent sighing/yawning; 5) frequent throat clearing; 6) muscle and joint 
tenderness in the upper chest; 7) cough; 8) chest tightness; 9) feeling of a lump in 
the throat; and 10) previous or current stress (Hagman et al., 2011).   The second 
group consisted of 25 participants, age and gender matched to the first group, with 
well managed asthma and without the presence of DB.   The DB group received 
between one and four individualised physiotherapy-based breathing retraining 
sessions, where participants were educated about breathing and taught 
diaphragmatic breathing techniques in different postures (Hagman et al., 2011).   All 
participants were required to complete five self-report questionnaires at baseline 
and at a 5-year follow up.  The authors did not report effect sizes for results but 
reported that statistically significant changes to physical function scores on the 
‘Medical Outcomes Survey Short Form 36 questionnaire’ were found (estimated as 
‘small to medium’ effects from published results).   Additionally, participants had 
fewer breathing problems in everyday activities (small to medium effect sizes) and 
the number of emergency room visits decreased in the DB group that received the 
intervention (Hagman et al., 2011).   The asthma group who did not receive the 
intervention recorded significantly lowered quality of health, and bodily pain at the 
5-year follow-up (Hagman et al., 2011).   
Chaitow (2007) and Gilbert (2003) both provide reviews of the literature surrounding 
the benefits of breathing retraining on common conditions.   Chaitow (2007) mainly 
discusses the benefits of breathing modification for hyperventilation syndrome for 
decreasing chronic pain and anxiety.   Chaitow (2007) states that there is ample 
evidence to support the possibility that hyperventilation syndrome may be a 
contributing factor to chronic pain and anxiety.  He concludes “breathing pattern 
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disorders are common, easily recognised, and commonly correctable via retraining 
and manual soft tissue (and sometimes osseous) mobilisation of respiratory 
structures” (Chaitow, 2007, p. 44).  The evidence Chaitow (2007) refers to 
throughout his review is largely anecdotal rather than higher quality evidence from 
epidemiological designs or controlled trials.    
Gilbert  (2003) recognises that breathing retraining has been used for many years 
and there is evidence to support its use in the treatment of anxiety.  Gilbert (2003) 
discusses the potential worth of breathing modification for purposes other than 
anxiety, such as rehabilitation from cardiovascular diseases, and decreasing 
symptoms of Chronic Obstructive Pulmonary Disease (COPD).   Gilbert (2003) 
concludes that that there is some evidence that breathing retraining may benefit 
these conditions, however, more research is required.  Gilbert’s conclusion that 
further research is required into the effectiveness of breathing retraining for 
conditions such as cardiovascular disease, or COPD appears justified as there is 
currently minimal supporting literature and existing evidence is largely anecdotal.   
Two high quality randomised controlled trials (Holloway & West, 2007; M. Thomas et 
al., 2003), and one recently published case-control study (Hagman et al., 2011) 
support the efficacy of breathing retraining for improvement of asthma symptoms 
and quality of life in asthma sufferers.   There is also a large amount of anecdotal 
evidence available demonstrating the potential benefits of breathing retraining for 
other conditions.  The available literature supports the possibility that DB may affect 
large numbers of people, and may influence many common conditions.   In healthy 
adults approximately 21,000 breaths are taken per day, therefore, because of the 
frequent repetitive motions of breathing, severe DB can have numerous implications 
on bodily functions, and some authors posit that even subtle forms of DB may be 
important (Courtney, 2009).   It is currently difficult to assess subtle changes in 
mechanical functions of breathing, therefore a valid diagnostic measure that is 
sensitive to a broad range of DB symptoms, may be beneficial for the early detection 
and appropriate management of DB. 
 
 
 
21 
 
4. Measures of Breathing Dysfunctions 
 
 
Several tools for the measurement of various forms of pathological breathing 
problems are available.   These tools include questionnaires mainly designed to 
measure the severity of diseases and quality of life in disease sufferers for specific 
respiratory conditions including COPD (Jones, Quirk, Baveystock, & Littlejohns, 1992; 
Meek, 2004; Wijkstra et al., 1994), emphysema (Eakin, Resinkoff, Prewitt, & Kaplan, 
1998), and asthma (Lee et al., 2009).   Five questionnaires have been identified that 
aim to recognise and quantify specific symptoms of breathing problems, these 
include: the Nijmegen Questionnaire (van Dixhoorn & Duivenvoorden, 1985; van 
Doorn et al., 1982); the Breathing Descriptor tool (Courtney & Greenwood, 2009; 
Meek, 2004); the Breathing Problems Questionnaire (Haave, Hyland, & Engivik, 2005; 
Hyland, Singh, Sodergren, & Morgan, 1998); the Rowley Breathing (RoBE) self-
efficacy scale (Rowley & Nicholls, 2006); and the SEBQ (Courtney & Greenwood, 
2009).  There are also manual assessment techniques available for the recognition of 
abnormal breathing patterns.  Examples of clinically applicable manual techniques 
include the Manual Assessment of  Respiratory Motion (MARM) (Courtney, van 
Dixhoorn, & Cohen, 2008); the Hi Lo Breathing Assessment (Courtney, Cohen, & 
Reece, 2009); and Breath Holding Time (Courtney & Cohen, 2008).   Currently there 
is no comprehensively validated diagnostic tool for identifying the wide range of DB 
signs and symptoms that have now been described.   The SEBQ has been developed 
with the aim to be a clinically applicable, self-report questionnaire that attempts to 
cover signs and symptoms of DB in detail.   
4.1. Questionnaires for Specific Conditions 
Most identified questionnaires related to breathing have been developed as 
assessments of severity, or quality of life of sufferers for specific pathological 
conditions.   Examples of disease-specific questionnaires include: the University of 
California, San Diego Shortness of Breath Questionnaire for the measurement 
dyspnea in daily activities, for moderate to severe chronic lung disease (Eakin et al., 
1998); the St.  Georges Questionnaire for chronic respiratory disease (Jones et al., 
1992); and, the Chronic Respiratory Questionnaire, which both assess quality of life 
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in COPD sufferers (Meek, 2004; Wijkstra et al., 1994); and the Asthma-Specific 
Quality of Life Questionnaire which assesses quality of life in asthma patients (Lee et 
al., 2009).  These disease-specific questionnaires are designed with the aim of 
quantifying secondary events occurring in response to the dyspnea sensations 
caused by the condition.  They do not directly quantify an individual’s perception of 
dyspnea sensations (Meek, 2004).  The design of these disease-specific 
questionnaires may not be appropriate for the identification of DB because their 
items are tailored specifically to quantify secondary events of pathological diseases 
and they fail to specifically describe dyspnea sensations.    
4.2. Questionnaires for Dysfunctional Breathing 
Questionnaires developed for the potential assessment of dyspnea sensations or DB 
include the Nijmegen Questionnaire (van Dixhoorn & Duivenvoorden, 1985; van 
Doorn et al., 1982), the Breathing Descriptor tool (Courtney & Greenwood, 2009; 
Meek, 2004), the Breathing Problems Questionnaire (Haave et al., 2005; Hyland et al., 
1998), the Rowley Breathing (RoBE) self-efficacy scale (Rowley & Nicholls, 2006), and 
the SEBQ (Courtney & Greenwood, 2009). 
4.2.1. The Nijmegen Questionnaire 
The only validated questionnaire that identifies DB is the Nijmegen Questionnaire 
(NQ), however, the NQ has only been validated for hyperventilation syndrome – 
which is just one form of DB (Courtney & Greenwood, 2009; M. Thomas et al., 2001; 
van Dixhoorn & Duivenvoorden, 1985).   The NQ was originally developed by van 
Doorn and colleagues (1982), who also performed a test-retest reliability study 
which showed the questionnaire to have high reliability (r = 0.87).   Validation studies 
of the NQ have involved comparison of NQ scores of participants diagnosed with 
hyperventilation syndrome using laboratory findings of hypocapnia, against 
participants without hyperventilation syndrome (Courtney & Greenwood, 2009; M. 
Thomas et al., 2001; van Dixhoorn & Duivenvoorden, 1985).   The NQ was found to 
be highly sensitive (Sn = 91%) for the recognition of hyperventilation syndrome with 
hypocapnia (van Dixhoorn & Duivenvoorden, 1985).   The NQ consists of 16 items 
each scored on a scale from 0, indicating the described symptom ‘never occurs’, to 4 
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indicating the symptom happens ‘very often’.   Normative values for the NQ are 
thought to be a mean score of 11 (SD 7.6) for a healthy population (Courtney, Cohen, 
et al., 2011), and a score of 23 or higher is thought to indicate hyperventilation 
syndrome (van Dixhoorn & Duivenvoorden, 1985).   Of the 16 NQ items, only four 
relate to breathing sensations directly, the others relate to neurological, 
psychological and cardiovascular symptoms (Courtney & Greenwood, 2009; van 
Dixhoorn & Duivenvoorden, 1985).  A recent study was performed on a sample of DB 
participants to determine the relationship between breathing pattern abnormalities 
and categories of NQ symptoms (Courtney, van Dixhoorn, et al., 2011).   
Dysfunctional breathing patterns were identified using a physical examination 
procedure involving palpation of the rib cage, the Manual Assessment of Respiratory 
Motion (Courtney, van Dixhoorn, et al., 2011).   The 16 NQ items were grouped into 
four categories of symptoms: ‘tension’, ‘central neurovascular’, ‘peripheral 
neurovascular’ and ‘dyspnea’.   Of these categories, dyspnea had the highest and 
only statistically significant correlation to MARM values for abnormal breathing 
patterns (r (38) = 0.32; P = 0.04) (Courtney, van Dixhoorn, et al., 2011).   According to 
(Courtney, van Dixhoorn, et al., 2011), the NQ has been designed to mainly recognise 
symptoms of one form of DB, and does not sufficiently identify all possible 
symptoms of DB.   Some of the symptoms of DB that are not incorporated into the 
NQ include: breath proportional to fitness, breath while talking, sighing, yawning, 
irregular breathing, breath holding, and mouth breathing (Courtney, Cohen, et al., 
2011; Courtney & Greenwood, 2009).   Therefore, a more detailed questionnaire 
that identifies a wider range of potential indicators of DB would be clinically useful. 
4.2.2. Other Measures of Dyspnea 
The Breathing Descriptor Tool is a validated questionnaire for identifying qualities of 
dyspnea sensations (Courtney & Greenwood, 2009; Meek, 2004).  Some of the 
Breathing Descriptor Tools items relate to DB, however, it has not been developed 
specifically for the use on DB individuals (Courtney & Greenwood, 2009; Meek, 2004).   
The Breathing Descriptor Tool has mainly been used to assess dyspnea sensations 
during laboratory manipulation of breathing, for example, during 
bronchoprovocation or exercise (Meek, 2004).   
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The Breathing Problems Questionnaire identifies some aspects of DB, however, the 
Breathing Problems Questionnaire has been designed as another disease-specific 
instrument to monitor the changes of self-perceived health status in individuals 
suffering from COPD (Haave et al., 2005; Hyland et al., 1998).   The Breathing 
Problems Questionnaire contains 33 questions that address physical and 
psychological quality of life in COPD sufferers, questions are worded specifically 
toward COPD patients and very few of the questions relate to symptoms of DB 
(Haave et al., 2005; Hyland et al., 1998).     
The only other questionnaire identified that has been developed to detect DB is the 
Rowley Breathing (RoBE) Scale for people with breathing pattern disorders (Rowley 
& Nicholls, 2006).   The RoBE Scale was developed as part of a pilot study, its items 
are mainly formulated from anecdotal descriptors of breathing recognised by the 
developers, and no further investigations into the questionnaire have been 
published since the original study (Rowley & Nicholls, 2006).   The RoBE Scale items 
refer to “your symptoms” rather than specifically detailing what the symptoms are 
and it appears to be more of an evaluation tool for the management of symptoms, 
rather than early detection of DB.   
None of the questionnaires previously discussed are ideal tools for identifying and 
measuring the severity of DB.   Disease-specific questionnaires may not be 
appropriate for the identification of DB because their items are tailored to quantify 
secondary events of pathological diseases and they fail to specifically describe 
dyspnea sensations.   The Nijmegen questionnaire has been specifically developed 
and validity tested for the recognition of hyperventilation syndrome (van Dixhoorn & 
Duivenvoorden, 1985; van Doorn et al., 1982) and does not sufficiently identify all 
possible symptoms of DB (Courtney, van Dixhoorn, et al., 2011).   The Breathing 
Descriptor Tool and the Breathing Problems Questionnaire identify some aspects of 
DB, however neither have been formulated specifically for DB.   The RoBE scale has 
been developed in an aim to quantify symptoms of DB, however, it was developed in 
a pilot study and minimal sources were used for development of its items.   There is 
currently no valid tool for the measurement of the broad range of signs and 
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symptoms of DB that have now been acknowledged. The SEBQ was developed in an 
aim to identify DB signs and symptoms.    
4.2.3. The Self Evaluation of Breathing Questionnaire (see Appendix A) 
The SEBQ is a comprehensive questionnaire that has been developed taking 
questions related to breathing from a variety of sources, in an aim to cover a wider 
range of potential symptoms of DB (Courtney & Greenwood, 2009).   Sources used 
for the development of the SEBQ include published studies by Burton (1993) and 
Howell (1990), which both proposed symptoms of DB, and other literature in the 
field that describes psychological and physiological aspects of breathing symptoms 
(Fried & Grimaldi, 1993; Wilhelm, Gertivz, & Roth, 2001).   Other sources for SEBQ 
development included clinical experience of the development team (Courtney & 
Greenwood, 2009), and a popular online questionnaire “How Good is your Breathing 
Test, Take our Free Breathing Test and See” (White, 2005).   In developing the SEBQ, 
Courtney and Greenwood (2009) required each SEBQ item to be supported by at 
least two sources in order to be included the questionnaire.   The original SEBQ 
contained 17 items relating to possible DB symptoms.   An exploratory study with 
preliminary investigation of the SEBQ was performed; factor analysis was carried out, 
and items with low factor loadings were removed from the questionnaire (Courtney 
& Greenwood, 2009).   Items with the highest factor loadings facilitated the 
identification of two distinct dimensions within the questionnaire (Courtney & 
Greenwood, 2009).   The two dimensions of the SEBQ that were identified were 
items related to a “lack of air” and items related to “perception of inappropriate or 
restricted breathing” (Courtney & Greenwood, 2009; Courtney, Greenwood, et al., 
2011).   The dimension “lack of air” was thought to be related to chemoreceptor 
inputs of DB or respiratory awareness of individuals with DB, all items in the SEBQ 
that contained descriptors about breathlessness loaded on this factor (Courtney & 
Greenwood, 2009).   The dimension “perception of inappropriate or restricted 
breathing” was seen to be more related to biomechanical aspects of DB, with items 
relating to a feeling of altered thoracic motion loading on this factor (Courtney & 
Greenwood, 2009).   The preliminary investigation also compared the SEBQ to the 
NQ in an aim to determine if the two measured different aspects of breathing 
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dysfunction to each other, it was concluded that the NQ does not strongly represent 
the two factors found on the SEBQ, therefore the SEBQ  cannot be relied upon to 
identify hyperventilation syndrome (Courtney & Greenwood, 2009).  According to 
results of the preliminary investigation, two SEBQ items were deleted due to low 
factor loadings (Courtney & Greenwood, 2009).   One item “I sigh yawn or gasp” was 
changed into two separate items “I notice myself sighing” and “I notice myself 
yawning” to make the items more specific (Courtney & Greenwood, 2009).  Eight 
additional items were added to the SEBQ from the Breathing Descriptor Tool in an 
aim to make the questionnaire more specific for DB symptoms; resulting in a revised 
25-item version of the SEBQ (Courtney & Greenwood, 2009).   
The SEBQ has been specifically developed from several sources in an aim to cover 
the broader range of signs and symptoms of DB that have now been acknowledged.  
Currently no reliability studies have been conducted on the SEBQ.   
4.3. Manual Assessments of Breathing 
The questionnaires previously discussed are patient-orientated, self-report measures 
of breathing dysfunctions.   There are also practitioner-orientated, manual 
assessments of breathing available for the diagnosis of DB.   Recently, studies have 
been conducted into the effectiveness of manual measures of DB.   Some of these 
clinically applicable manual measures of DB include the ‘Manual Assessment of 
Respiratory Motion’ (MARM) (Courtney et al., 2008), ‘Hi Lo Breathing Assessment’ 
(Courtney et al., 2009), and ‘Breath Holding Time’ (Courtney & Cohen, 2008). 
4.3.1. The Manual Assessment of Respiratory Motion 
The MARM is a physical examination procedure in which examiners assess rib cage 
motion using palpation.   A standardised graphical notation of the examiner’s 
impression of respiratory motion is used to record findings and from this a numerical 
value of amount and quality of movement of the rib cage can be derived (Courtney, 
Cohen, et al., 2011; Courtney et al., 2008).  MARM values can range between 0 and 
180 (Courtney et al., 2008) and two separate values can be determined.  The first is a 
MARM balance measure, for measuring balance between different areas of rib cage 
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movement during breathing.   The second measure is a MARM percentage of rib 
cage motion, for evaluating the extent of rib cage motion during breathing (Courtney, 
Greenwood, et al., 2011).   A MARM balance value of 6 is considered to be normal 
and values over 30 are thought to be dysfunctional (Courtney, Greenwood, et al., 
2011).   A MARM percentage of rib cage motion value of 56 is considered to be 
normal and values over 70 are thought to be dysfunctional (Courtney, Greenwood, 
et al., 2011).   A validation study of the MARM was completed where inter-examiner 
reliability was assessed, and MARM scores were compared to Respiratory Induction 
Plethysmography measures (Courtney et al., 2008).  Respiratory Induction 
Plethysmography uses an electronic instrument used in research settings for the 
evaluation of breathing patterns; it involves two fitted motion detecting bands, one 
around the upper thorax and the other around the upper abdomen (Courtney et al., 
2008).   These motion detecting bands record measurements of chest expansion, the 
measurements are then automatically exported to data analysis software (Courtney 
et al., 2008).   Results for the validation study of the MARM indicated that overall 
inter-examiner agreement using the MARM was good (ICC=0.85; 95% CI 0.78 to 0.89).  
The authors also reported and that there was a strong and statistically significant 
correlation between MARM balance and Respiratory Induction Plethysmography 
values (r = 0.597; P = 0.01).  The correlation between MARM percentage of rib cage 
motion and Respiratory Induction Plethysmography was much lower (r = 0.21; P < 
0.05)  (Courtney et al., 2008).   Based on the outcome of this study authors 
concluded that the MARM is a valid and reliable clinical tool for assessing breathing 
pattern (Courtney et al., 2008).  There has only been one validation study of the 
MARM. It was conducted on a sample of people mimicking DB patterns, and the 
correlations between MARM percentage of rib cage motion and Respiratory 
Induction Plethysmography were weak.   Before the MARM can be considered a valid 
tool for the identification of DB, further investigation should be performed to repeat 
and improve the validity findings.   Performing a validation study in a sample of 
people with clinically observed DB would be useful.   
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4.3.2. Hi Lo Breathing Assessment and Breath Holding Time 
The Hi Lo Breathing Assessment is both a visual and manual technique used to 
determine the presence of paradoxical breathing and assess the rate and rhythm of 
breathing (Courtney et al., 2009).   Examiners undertaking Hi Lo palpate the upper 
chest and the upper abdomen of the patient to qualitatively evaluate the dominance 
and coordination of the two areas during respiration (Courtney, Cohen, et al., 2011).   
The Hi Lo Breathing Assessment is considered to be a reasonably accurate measure 
of a paradoxical breathing pattern. However, patterns of DB other than paradoxical 
breathing such as abnormal lateral breathing patterns may be missed using this 
method (Courtney, Cohen, et al., 2011).   
Breath holding time is thought to be of shorter duration in people with 
hyperventilation syndrome or DB patterns and has been used as a measure of DB 
(Courtney & Cohen, 2008).  The results of breath holding time are strongly 
dependent on how the technique is performed, therefore breath holding time is not 
reliable unless examiners utilise a standardised protocol.   
4.4. Reliability of Assessment Tools 
Reliability can be defined as “the consistency or repeatability of measurements: the 
degree to which measurements are error-free, and the degree to which repeated 
measurements will agree” (Rothstein et al., 1991).   High reliability indicates 
precision of single measurements and ensures better tracking of changes in 
measurements, either in a research or practical settings (Hopkins, 2000).  The two 
most important aspects of determining measurement error of a tool are thought to 
be criterion-related validity and test-retest reliability (Hopkins, 2000).   In a review of 
measures of reliability, Hopkins (2000) discusses the three most important types of 
measures for evaluating reliability, which he believes to be within-subject variation, 
change in the mean, and test-retest correlation.   Within-subject variation is the 
variability in the test measure for a typical individual undergoing a series of repeated 
tests and has been suggested to be the most important type of reliability for 
practitioners wanting to monitor change in clients (Hopkins, 2000).   Within-subject 
variation may be calculated as standard error of measurement (also termed 
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technical error of measurement or within-subject standard deviation) or as limits of 
agreement (Bland & Altman, 2010; Hopkins, 2000).   In fact, standard error of 
measurement is proportional to the Bland-Altman statistic used to calculate the 
limits of agreement (Hopkins, 2001).  Hopkins (2000) believes that standard errors of 
measurement are superior statistics to report in studies of reliability than limits of 
agreement.  In his review and later website articles (Hopkins, 2000, 2001), Hopkins 
provides two main reasons for this.  The first reason is that he believes that standard 
error of measurement calculations are easier to understand than Bland Altman limits 
of agreement in that they represent meaningful statistical concepts, i.e, both error in 
a single measurement or variability in measures obtained from multiple 
administrations of the test in the same individual.  Bland-Altman limits of agreement, 
in contrast, are often incorrectly misinterpreted as 95% confidence intervals for the 
difference between two tests, although they are not such.  For inferential statistical 
interpretation, or further statistical calculations, either the confidence intervals for 
limits of agreement must be calculated, or the limits must be converted to standard 
errors of measurement.  Secondly, Hopkins (2000) believes that the range produced 
using Bland-Altman limits of agreement is too large for most purposes. 
Change in the mean between tests is also a simple yet important measure of 
reliability (Hopkins, 2000).  Test-retest correlations are also important and represent 
how closely the value of one trial tracks the value of another, and how well the 
ranking order of participants in one trial is replicated in a second trial (Hopkins, 
2000).   Hopkins (2000) points out that, whilst test-retest correlation is a very useful 
statistic to report in the evaluation of reliability, it is sensitive to the spread of values 
between participants and should thus be reported in conjunction with standard 
error of measurement and changes in the mean between tests.   Intraclass 
Correlation Coefficient (ICC) is deemed an appropriate statistic to represent the 
correlation between two trials (Hopkins, 2000). 
In summary, reliability testing is an essential part of the development of any tool.   
Manual techniques such as MARM (Courtney et al., 2008), Hi Lo Breathing 
Assessment (Courtney et al., 2009) and Breath Holding Time (Courtney & Cohen, 
2008) require more time to perform than a questionnaire, therefore making a 
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questionnaire potentially, a more practical tool for the routine clinical detection and 
measurement of DB.   Many of the questionnaires explored in this review may not be 
suitable assessment tools for the detection of DB.   The SEBQ could be considered to 
be the most specific and clinically applicable tool for assessing DB.   Although the 
revised version of the SEBQ has been developed specifically for the assessment of DB 
from a wide range of sources and has had a thorough preliminary investigation, to 
date, no reliability study of the SEBQ has been performed.   
5. Potential Predictors of SEBQ Score 
 
 
There are currently no published data about the correlates or predictors of the SEBQ 
score. However, many lifestyle and demographic variables are thought to be affected 
by, or have influence over, breathing and therefore it would follow that they may 
affect SEBQ score.   Dysfunctional breathing is potentially associated with a range of 
variables including age, gender, physical activity level, Body Mass Index (BMI), 
current smoking, occupation type, cardiovascular or respiratory disease, or recent 
respiratory illness.   
5.1. Age and Gender 
There is currently no literature to suggest that either age or gender may correlate 
with DB.   There is, however, evidence to suggest that gender has an association with 
the presence of psychological issues including anxiety and depression, with the 
prevalence being higher in females than males (Penninx et al., 2011).   Anxiety is 
known to have a strong influence over breathing patterns and the presence of 
hyperventilation syndrome (Han, Schepers, Stegen, Van den Bergh, & Van de 
Woestiijne, 2000; Han et al., 2004; Lum, 1987).   Therefore, the association between 
gender and DB should be investigated.   
5.2. Physical Activity and Obesity 
Previous studies have linked both low physical activity level and obesity with an 
increased risk of development of respiratory conditions such as asthma (Kilpelainen, 
Terho, Helenius, & Koskenvuo, 2006), obstructive sleep apnoea and obesity 
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hypoventilation syndrome (Murugan & Sharma, 2008).   One crude measure of 
obesity is body mass index (BMI) which combines height and weight in a single 
metric and allows comparison to normative data.   Using BMI, individuals are 
classified as underweight, normal, overweight, obese or morbidly obese (Murugan & 
Sharma, 2008).   Physical activity level and obesity have been recognised to be highly 
inversely correlated, when one increases the other decreases and vice versa (Keim, 
Blanton, & Kretsch, 2004; Schoenborn & Stommel, 2011).   Due to the correlations of 
physical activity level and obesity with respiratory conditions, it is possible that these 
two variables are also associated with the presence of DB.   Occupation strongly 
influences the activity level of adults and certain occupations may therefore be 
linked to DB prevalence or severity (Keim et al., 2004).   
5.3. Smoking and Respiratory Conditions 
Smoking has a potent influence over the respiratory system, and is a strong risk 
factor for chronic respiratory conditions including COPD (Urrutia et al., 2005), 
chronic bronchitis, and emphysema (Vukovic, Nagorni-Obradovic, & Vukovic, 2010).  
Therefore, it would be unsurprising if smoking was also seen to be linked to the 
prevalence of breathing dysfunction.   People with structural or pathological 
breathing problems are thought to be more at risk of developing DB patterns (M. 
Thomas, 2003).   Several previous studies that investigate correlation between 
asthma and DB have been undertaken.  The studies concluded that hyperventilation 
syndrome is more common in asthmatics than in non-asthmatic, and that 
hyperventilation syndrome may worsen asthma symptoms (Stanton et al., 2008; M. 
Thomas, 2003; M. Thomas et al., 2001; M. Thomas, McKinley, Freeman, Foy, & Price, 
2005).   Due to the strength of the correlations found between DB and respiratory 
conditions, respiratory conditions may also influence SEBQ scores.   Cardiovascular 
problems are known to manifest with breathing difficulties, therefore, cardiovascular 
problems may influence DB patterns (Longmore, Wilkinson, Turmezei, & Cheung, 
2007). 
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6. Conclusions 
 
Respiration is essential for all processes occurring within the body.  Dysfunctional 
breathing appears to be common and may have a range of mild to severe adverse 
effects on the health of an individual.   There is currently no validated tool for the 
diagnosis or measure of severity of the broader definition of DB that has recently 
been described.   The SEBQ is a new tool that aims to assess the broader range of DB 
signs and symptoms that have recently been acknowledged.   The SEBQ can be 
considered the most relevant and clinically applicable tool for the assessment of 
signs and symptoms of DB.   To date no previous validation studies or investigations 
into the correlates or potential predictors of the SEBQ have been reported.   A study 
determining the test-retest reliability, the correlates, and the potential predictors of 
SEBQ score is relevant and will provide the first essential step towards the validation 
process of the SEBQ.   Section two of this thesis reports an investigation which aims 
to: determine the test-retest reliability of the SEBQ; and to investigate potential 
lifestyle or demographic variables that may be associated with, or may predict, SEBQ 
scores. 
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1. Abstract 
Background: Dysfunctional breathing (DB) is characterised by an abnormal breathing 
pattern leading to respiratory symptoms. However, DB is not currently well defined 
and has no criterion measure. The Self Evaluation of Breathing Questionnaire (SEBQ) 
has been recently developed to measure DB symptoms and their severity but lacks 
thorough evaluation. Objectives: To determine the test-retest reliability and to 
identify lifestyle or demographic predictors of SEBQ score. Method: A 
heterogeneous sample of participants (n=180) completed the SEBQ and lifestyle and 
demographic questions. Two weeks later, 156 participants completed the SEBQ and 
lifestyle questions again. Results: Test-retest correlation of the SEBQ was high 
(ICC=0.88; 95% CI 0.84 to 0.91). There was no difference in SEBQ score between test 
and retest (15.4 ± 11.6 versus 14.7 ± 12.4; CI for difference -0.6 to 1.2; P = 0.53) and 
had a standard error of measurement of 4.1. Variables found to be independently 
related to SEBQ score in a regression analysis included smoking status (P = 0.005), 
reported respiratory disease (P ≤ 0.001) and recent respiratory illness (P = 0.04). 
Multiple regression models included these three variables and female gender as 
predictors of SEBQ score which together explained 25.6% of variability in SEBQ 
scores (P ≤ 0.001). Conclusions: The SEBQ has high test-retest reliability. SEBQ scores 
may be predicted by current smoking, chronic respiratory disease, recent respiratory 
illness and female gender. Further studies to further validate the SEBQ are required. 
If shown to be valid, the SEBQ could be a useful clinical screening tool for early 
detection of DB.  
Keywords: Dysfunctional breathing, Breathing symptom questionnaire, Test-retest 
reliability, Dysfunctional breathing determinants. 
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2.  Introduction 
 
Until recently, hyperventilation syndrome with the presence of hypocapnia was 
considered the only form of dysfunctional breathing (DB).  However, it has recently 
been acknowledged that a broader definition is required as DB related symptoms 
and abnormal breathing patterns can occur with normal carbon dioxide levels in the 
body [1-3].  Current definitions of DB remain unclear.  DB is a term that has recently 
been applied to a range of associated signs and symptoms that often occur together 
and may have a range of underlying causes.  Dysfunctional breathing is thought to 
have several contributing causative factors arising from biomechanical, biochemical 
and psychophysiological influences [4].  In practice, DB may result in breathing which 
is either inefficient or inappropriate for the needs of the individual at the time [5].  It 
has been estimated that DB affects approximately 5-11% of the general population, 
30% of asthmatics and up to 83% of anxiety sufferers [5-7]. Dysfunctional breathing 
is thought to be associated with many common conditions, such as asthma [3, 7, 8], 
cardiovascular disease [4, 9], myofascial pain syndromes [5, 10, 11], 
temporomandibular joint disorders [10], altered spinal stability, headaches and 
migraines [5, 10].  
 
In the past DB has been imprecisely characterised as ‘hyperventilation syndrome’ 
therefore, no validated method exists for its assessment.  In clinical practice DB may 
be identified using manual techniques such as the Manual Assessment of Respiratory 
Motion [12], the Hi Lo Breathing Assessment [13], and Breath Holding Time [1].  
Clinical observations and symptom identifying questionnaires, such as the Self 
Evaluation of Breathing questionnaire (SEBQ) [2], or the Nijmegen Questionnaire [14, 
15] are also used in clinical practice for identifying DB.  The only validated 
questionnaire currently available for the measurement of symptoms of DB is the 
Nijmegen Questionnaire, which has been validated only for detection of 
hyperventilation syndrome [14, 15].  The Nijmegen Questionnaire has been validated 
by comparing the scores of participants who have been diagnosed via laboratory 
findings of hypocapnia with hyperventilation syndrome, against participants without 
hyperventilation syndrome [14].  The Nijmegen Questionnaire includes items about 
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psychological, neurological and cardiovascular symptoms, but contains only four 
items specifically related to breathing [2].  A recent study that compared results of 
the Nijmegen Questionnaire to those of the Manual Assessment of Respiratory 
Motion on DB patients, showed that breathing items and some items related to the 
‘feeling of tension’ on the Nijmegen Questionnaire were related to DB patterns, but 
that the remaining 9 items were not [4].  
 
The SEBQ was developed in response to a need for a comprehensive screening tool 
to identify potential indicators of DB [2].  The SEBQ includes items related to 
breathing drawn from a wide variety of sources, in an aim to cover the broader signs 
and symptoms of DB that have now been acknowledged [2].  Sources used for the 
development of the SEBQ include published studies by Burton [16] and Howell [17], 
who both proposed symptoms of DB and other literature in the field that describes 
psychological and physiological aspects of breathing symptoms [18, 19].  Other 
sources for SEBQ development included the clinical experience of the development 
team [2], and an online questionnaire [20].  Each SEBQ item was supported by at 
least two of these sources in order to be included in the questionnaire and 
preliminary investigations have been performed, resulting in a revised 25 item 
version of the SEBQ [see Appendix A] [2].  To date no previous reliability studies or 
investigations into the correlates or potential predictors of the SEBQ have been 
reported.  A study determining the test-retest reliability, the correlates, and the 
potential predictors of SEBQ score is required and will provide an essential step 
towards validating the SEBQ. 
 
The aims of this study were to: 1) determine test-retest reliability of the SEBQ as a 
measure of dysfunctional breathing; and, 2) identify determinants of SEBQ scores, 
and examine their relationship with demographic and lifestyle variables.  
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3.  Methods 
3.1. Study Sample 
Participants were recruited using convenience sampling through an online service 
that offers strategic online and social marketing assistance for study promotion and 
recruitment (http://www.getparticipants.com).  All participants were required to be 
over 18 years and able to read and understand English.  Exclusion criteria were 
planning major lifestyle changes during the 2-week duration of data collection (e.g., 
cessation of smoking, major changes to physical activity level or diet); and known 
disease or illness entailing incapacitation or considerable periods of bed rest.  
Prospective participants read information on the site about the study [see Appendix 
C], registered their interest, supplied their email address and then were emailed a 
link to a questionnaire hosted online (http://www.surveymonkey.com).  The study 
was approved by the Unitec Research Ethics Committee (Approval number: 2010-
1089) [see Appendix D].  
3.2. Data Collection  
Test-retest reliability of the SEBQ was assessed using measures recorded at a 14-day 
interval. Participants were asked to complete the two questionnaires at a 14-day 
interval on the same day of the week and as close to the same time of day as 
possible [see Appendices E and F].  SEBQ items were randomised for the retest in an 
attempt to minimise recall bias.  In addition to the 25-item SEBQ, both 
questionnaires comprised lifestyle, demographic and health questions.  Physical 
activity and smoking were assessed using questions adapted from the validated Life 
in New Zealand Survey [21, 22].  Other lifestyle, demographic and health variables 
were assessed using questions designed and trialled prior to recruitment.  
Occupational classifications were based on those established by Statistics New 
Zealand [23].  Physical activity level was estimated using validated energy 
expenditure tables for activities reported by participants in their questionnaire 
answers [24].  
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3.3. Data Analysis 
Test-retest reliability was assessed by calculating the Intraclass Correlation 
Coefficient (ICC) and interpreted according to the descriptors of effect size suggested 
by Hopkins [25]. As recommended by Hopkins [26], bias between test and retest 
applications of the questionnaire was determined using paired t-tests and standard 
errors of measurement (proportional to Bland-Altman Limits of Agreement [27]) 
were also reported. Uniformity of error was assessed by visual inspection of a plot of 
the change in SEBQ score over the average SEBQ score [25].   
Cross-sectional univariate relationships with the SEBQ score obtained from the first 
questionnaire were investigated using t-tests for dichotomous variables (gender, 
occupation type, smoking and reported cardiovascular and respiratory disease status 
and presence of respiratory illness within 2 weeks prior to the study) and Pearson’s r 
for continuous variables (age, BMI, and physical activity level).  First questionnaire 
responses (Test 1) were used both to determine univariate relationships, and in the 
regression analysis, as very few lifestyle changes were reported by participants 
between tests and appeared to have minimal influence over SEBQ scores. 
Both dichotomous and continuous variables were entered as potential predictors of 
SEBQ score into a backward stepwise regression model using a level of significance 
for removal from the model of P ≥ 0.05, and P < 0.05 for retention.  As suggested by 
Field, regression statistics were reported from a subsequent model that forced entry 
of all variables retained during backward regression [28].  Responses to individual 
SEBQ items, from first questionnaire responses were inspected for variability, or lack 
thereof, using descriptive statistics.  All data were analysed using SPSS v18 (IBM 
Corp., NY).  Data are expressed as mean  SD unless otherwise stated. 
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4. Results 
A total of 180 participants were recruited for this study: three participants 
completed only demographic details and the SEBQ questionnaire itself, but did not 
provide lifestyle information for the original questionnaire.  A total of 156 
participants, 86.7% of the original sample, completed the follow-up questionnaire 
and retest SEBQ. Baseline characteristics for all participants are outlined in Table 1.  
4.1. Test-Retest Reliability 
The difference in SEBQ score from test to retest did not vary as a function of the 
magnitude of SEBQ (data not shown) [see Appendix G]. The Intraclass Correlation 
Coefficient of agreement for test-retest SEBQ scores indicated a high level of 
correlation between tests (ICC=0.88; 95% CI=0.84 to 0.91). There was no difference 
in SEBQ score between test and retest (SEBQ Test 1 = 15.4 ± 11.6 compared to SEBQ 
at Test 2 = 14.7 ± 12.4; 95% CI for the difference -0.6 to 1.2; P = 0.53) (Figure 1). 
Standard error of measurement of SEBQ score was 4.1. 
4.2. Baseline Univariate Data Analysis 
Dichotomous variables that produced statistically significant differences in mean 
SEBQ scores were current smoking status (P = 0.005); reported respiratory disease (P 
≤ 0.001); and reported respiratory illness in the two weeks prior to the study 
(respiratory illness) (P = 0.04).  Reported cardiovascular disease, female gender and 
active occupation did not result in statistically significant differences in mean SEBQ 
scores; differences in the means for all variables are outlined in Table 2.  Although 
BMI was weakly correlated with age (r = 0.163; P = 0.030) and physical activity level 
(r = 0.159; P = 0.034), none of these, or other demographic variables were related to 
SEBQ score (Table 3). 
A total of 34 smokers participated in the study, 14 of these participants also reported 
having respiratory disease or illness.  All participants with the presence of respiratory 
disease or illness were removed from the analysis to determine if smoking without 
the presence of respiratory problems influenced mean SEBQ score.  Smoking without 
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the presence of respiratory disease or illness still produced statistically significant 
differences in mean SEBQ scores (P = 0.01) (Table 2).  
Frequency distributions are displayed for SEBQ score in the overall sample (Figure 2) 
and in asthmatics (Figure 3).  The prevalence of DB has been estimated to be 5-11% 
of the general population; up to 30% of asthmatics and up to 83% of anxiety 
sufferers [5-7].  Specific statistics could not be calculated from the current data as 
there is not yet a specific SEBQ score that indicates an individual is a ‘dysfunctional 
breather’.  Figure 2, however, shows frequency distribution in the overall sample is 
slightly positively skewed (skewness= 1.5; 95% CI 1.1 to 1.9) compared to asthmatics 
(skewness= 1.3; 95% CI 0.5 to 2.1) (Figure 3) thus implying that there is a lower 
average SEBQ score in the overall sample than the asthmatic population. 
4.3. Regression Model 
Predictor variables entered into the model included BMI, gender, age, physical 
activity level, smoking, occupational activity level, presence of cardiovascular disease, 
presence of respiratory disease, and presence of respiratory illness within two weeks 
prior to the study.  Variables retained in the backwards regression model all 
positively predicted baseline SEBQ score and were; female gender, current smoking, 
reported respiratory disease, and presence of respiratory illness in the last two 
weeks.  Cumulatively, these explained 25.6% of the variability in SEBQ scores (P ≤ 
0.001). The same results were found when the entry method for the regression was 
‘forced’ into a subsequent model.  
In order to determine if any of the potential predictors had more influence in a 
population without respiratory complaints, the regression analysis was repeated, 
this time removing all participants with known respiratory problems.  In this analysis 
the only predictor of SEBQ score remaining in the model was current smoking which 
explained 15.6% of variability in SEBQ scores (P ≤ 0.001). 
4.4. Individual Item Analysis 
Particular symptoms from the 25-item SEBQ questionnaire were more commonly 
reported than others.  Table 4 lists individual items in order of prevalence; details 
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the sum of total scores for each item; and shows the mean SEBQ score for 
participants who reported having some degree of the described symptom by scoring 
themselves ≥ 1 on the item.  Items with a high response rate (number of positive 
answers and higher sum of scores) have a lower average SEBQ score for individuals 
with a positive response to this item and vice versa. 
 
5. Discussion 
 
Prior to this study there had been no research conducted investigating the reliability 
of the SEBQ as a measure of dysfunctional breathing.  This research set out to 
determine the test-retest reliability and identify determinants of SEBQ score and has 
shown that the SEBQ has a high level of agreement in a sample drawn from a general 
population.  Therefore, the SEBQ can be considered a reliable tool and data here 
contribute evidence towards validation of this instrument.  
At present, it is difficult to evaluate the validity of any item relating to DB as there is 
neither a set definition of DB nor an established criterion measure for it.  
Dysfunctional breathing has however been recognised in a clinical setting for many 
years and is considered to be a significant contributing factor to many conditions 
seen by healthcare practitioners [5].  Dysfunctional breathing has the potential to 
considerably lower quality of life for individuals experiencing its symptoms [29].  
Dysfunctional breathing is thought to be associated with musculoskeletal conditions 
such as headaches [5, 30], temporomandibular joint pain [10], neck, shoulder, thorax 
and lower back pain [5, 11], and non-musculoskeletal conditions such as chronic 
fatigue [11], anxiety and depression [31], hypertension, irritable bowel syndrome, 
and hypersensitivity to pain [11].  Dysfunctional breathing is important clinically and, 
therefore, a valid, easy-to-use tool for its identification may be beneficial to help 
increase detection and encourage appropriate management such as breathing 
retraining. 
Breathing retraining may involve a practitioner providing education about ideal 
breathing, and breathing exercises to a patient in an aim to improve the 
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physiological function of a person’s breathing mechanics.  Breathing retraining has 
been shown in previous studies to decrease the disabling affects of DB on the 
conditions stated above [11, 29, 32, 33].  A recent study conducted in Sweden 
examined the long-term effects of an individualised breathing retraining program on 
DB participants as compared to asthmatic participants with no intervention [32].  
Participants at a 5-year follow up who had received the breathing retraining program 
had improved physical function health-related quality of life, had fewer breathing 
problems with every day activities and fewer emergency room visits compared to 
baseline and participants who did not receive the intervention [32].  The Swedish 
study [32] highlights the potential usefulness of an instrument for the early 
detection of DB, which may then lead to appropriate management.  
5.1. Predictors of SEBQ Score 
The current cross-sectional analysis revealed that few lifestyle and demographic 
variables were predictive of SEBQ scores.  Unexpectedly, only three variables were 
found to produce significant differences in mean SEBQ score, including current 
smoking; the presence of chronic respiratory disease (respiratory disease); and 
participants reporting a history of respiratory illness within two weeks prior to the 
study (respiratory illness).  These three variables, together with female gender were 
found to be predictors of SEBQ score. When all participants with respiratory 
problems were removed, the only variable that still influenced SEBQ score was 
smoking. 
5.1.1. Smoking 
In the current study, participants who currently smoked scored, on average, 51% 
higher on the SEBQ than those who didn’t smoke.  Smoking has a potent influence 
on the respiratory system and is known to be a leading risk factor in respiratory 
diseases such as chronic obstructive pulmonary disease (COPD) [34], chronic 
bronchitis, and emphysema [35].  It is therefore unsurprising that smoking was found 
to be an important determinant of DB.  When smokers who reported either having 
been diagnosed either with a chronic respiratory disease or had recently 
experienced an acute respiratory infection were removed from analysis smoking still 
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influenced SEBQ score.  For people without respiratory problems smokers, on 
average, scored 90% higher than non-smokers on the SEBQ.  
The mechanisms by which smoking might influence breathing symptoms and/or 
patterns, in the absence of detectable pathologies are unclear, however a number of 
theories have been investigated.  There is evidence to suggest that smoking may 
alter the responsiveness of the respiratory centres to carbon dioxide levels [36].  A 
previous study measured respiratory centre regulation in non-smokers and in 
smokers without known disease [36]. In this study, measurements were made of 
mouth occlusion pressure during carbon dioxide (a respiratory stimulant) 
rebreathing and passive tilt from supine to standing; passive tilt is thought to 
increase ventilation volume in healthy individuals [36].  A reduced respiratory 
response to carbon dioxide stimulation and no increase in ventilation volume from 
supine to standing was reported in smokers [36].  This decreased respiratory drive in 
smokers may be one reason for the higher DB symptom scores observed in the 
current study.   
It has also been shown that smoking in individuals without known disease may result 
in respiratory tract inflammation [37].  The presence of inflammatory cells in both 
the sputum and tissue biopsy have been observed in healthy smokers as compared 
to non-smokers [37].  Healthy smokers, however, have significantly less 
inflammatory mediators than symptomatic smokers (cough or sputum production) 
or smokers with respiratory disease [37].  There is a strong positive correlation 
between the number of cigarettes smoked per day and lung function, as measured in 
participants by forced expiratory volume in one second (FEV1) and forced vital 
capacity (FVC) [34].  The higher number of cigarettes participants smoke the more 
impaired their lung function and lung volume [34].  It is possible that decreased lung 
volumes and mild inflammatory processes occurring in the airways of healthy 
smokers may result in mild respiratory symptoms that manifest as DB and are 
therefore being detected by the SEBQ.   
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5.1.2. Respiratory Conditions 
In the current study participants with reported respiratory disease scored, on 
average, 69% higher on SEBQ than those without.  Participants with acute 
respiratory infection scored, on average, 29% higher on SEBQ than those without.  It 
was anticipated that participants with diagnosed respiratory conditions or acute 
respiratory infections would have higher SEBQ scores than those without these 
conditions, as some of the symptoms of DB may result from respiratory pathology or 
infection.  There are several studies that suggest that DB, when it was previously 
defined as hyperventilation syndrome, was prevalent in people with respiratory 
disease, particular asthma [3, 7, 8, 38].  It has been shown that hyperventilation 
syndrome is common in people with asthma, and is associated with more severe 
asthma symptoms [3, 7, 8, 38].  Asthma was specifically examined in the current 
study with the use of frequency distributions (Figure 2 and 3) that show that in this 
sample mean SEBQ score was slightly higher in the subgroup with asthma compared 
to the overall sample.  Some symptoms of hyperventilation with hypocapnia, may 
overlap with symptoms of DB patterns [4].  In a recent study the Manual Assessment 
of Respiratory Motion (MARM) was used as a measure of DB in participants with 
medically unexplained dyspnea; MARM results were then compared to results of the 
Nijmegen Questionnaire for symptoms of hyperventilation syndrome to determine 
correlating factors [4].  Nijmegen Questionnaire items were grouped into four 
symptom factors’ ‘dyspnea’, ‘peripheral’, ‘central’ and ‘tension’ [4]. Participants with 
DB as measured by the MARM, were reported to have symptoms that related to 2 
out of the 4 factors on the Nijmegen Questionnaire; including ‘dyspnoea’ and 
‘tension’ [4].  On the basis of relating respiratory diseases to hyperventilation 
syndrome, and the relationships between symptoms of DB and hyperventilation 
syndrome; the association between respiratory issues and SEBQ score was expected.  
5.1.3. Gender 
Regression analysis in this study showed that female gender may predict higher 
SEBQ score. The reason for this association is unclear from these data.  However, 
one explanation may be that male gender was underrepresented in the study sample.  
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Another possible reason for the association between female gender and DB may be 
due to the higher prevalence of anxiety and depression in females [39].  Anxiety is 
known to have a strong influence over breathing pattern and the prevalence of 
hyperventilation syndrome and DB patterns are also likely to be more prevalent in 
people with anxiety [40-42].  Psychological indices such as stress, distress, 
depression and anxiety were not measured in the current study and future 
investigation of links between psychological state and DB would be useful.  
5.2. Variables Unrelated to SEBQ Score 
The very low correlation found between physical activity levels, BMI, age, occupation, 
and reported cardiovascular problems with SEBQ score was unexpected, but 
supports the possibility that DB affects a wide range of people and that lifestyle 
factors have little influence.  No previous studies could be found investigating 
correlations between age and DB; age was found to have a low correlation with 
SEBQ score in the current study.  
5.2.1. Physical Activity and BMI 
In previous studies physical activity level has been shown to be related to respiratory 
disease; those who are less active have an increased likelihood of developing 
diseases such as chronic bronchitis, emphysema and asthma [35, 43].  Activity, 
estimated in the current study as self-reported cumulative energy expenditure in 
regular physical activities, was not a predictor of SEBQ score.  The reason for this lack 
of relationship between physical activity and SEBQ score is unknown; the accuracy of 
self-reports of physical activity are questionable [44]. The only variable that 
correlated with physical activity level was Body Mass Index (BMI) and it is well 
established that regular physical activity is associated with a lower BMI [45].  In this 
study there was a weak positive correlation between physical activity level and BMI 
leading to paradoxical findings; participants with a higher physical activity level 
tended to have a higher BMI and vice versa.  The reason for this paradoxical finding 
is unclear, although, may be attributed to BMI being a poor measure of healthy body 
composition [46].  There is evidence to suggest that obesity influences breathing 
pattern, respiratory drive and gas exchange [47], however, in the current study BMI 
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was poorly correlated with SEBQ score.  BMI is not an accurate measure of body 
composition [46] and further investigation into the relationship between obesity and 
DB should utilise accurate measures of body composition.    
5.2.2. Occupation 
In this investigation, occupation type was weakly correlated with SEBQ score.  
Occupations were classified according to activity level without other possible 
influences being taken into account.  Since physical activity level was weakly 
correlated with SEBQ score, it follows that occupational activity level would also 
have a weak correlation.  There is evidence to suggest that psychosocial 
occupational stressors may influence breathing patterns [48].  Future studies could 
usefully assess the relationship between DB and other characteristics of occupation 
not considered here such as occupational stressors. 
5.2.3. Cardiovascular Problems  
Based on the weak correlation between SEBQ score and presence of self-reported 
cardiovascular problems it could be that SEBQ discriminates between cardiovascular 
symptoms and DB; despite the observation that cardiovascular problems can 
manifest with breathing difficulties [49].  The Nijmegen Questionnaire for 
assessment of hyperventilation syndrome contains items that relate to 
cardiovascular symptoms, for example chest pain, tingling fingers and cold hands or 
feet [4, 14].  These cardiovascular symptom items have been seen to be to only 
relate to hyperventilation syndrome with presence of hypocapnia, and not DB with 
normal carbon dioxide levels [4].  
5.3. Limitations of the Study 
In this study one retest was performed; it is possible that a larger number of re-tests 
may provide a more accurate indicator of the reproducibility of the SEBQ [25].  The 
re-test timeframe may have also influenced results, a two week period was selected 
in an attempt to minimise errors caused by seasonal change that may influence 
participants’ respiratory function.  Participants were asked to complete the test and 
re-test questionnaires on the same day of the week and approximately the same 
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time of day, the assumption being that majority of participants would have a similar 
routine week to week and therefore, decreasing the chance of participants 
performing a different activity between questionnaires that may change their 
breathing symptoms.  A longer period between retests may have further decreased 
the likelihood of bias of participants remembering previous answers. 
Another possible limitation of this study is recruitment bias.  Inclusion and exclusion 
criteria here were designed to recruit a heterogeneous population. However, the 
method of recruitment may have led to participants being similar in lifestyle choices 
and demographics.  Some subgroups of the general population may have been 
inadequately represented and reliability may be different in another demographic 
group. 
5.4. Further research 
Dysfunctional breathing is challenging to research as there is currently little 
consensus surrounding its definition and optimal measurement.  There is currently 
no standardised protocol for quantification of DB and this presents difficulties for 
further validation studies of the SEBQ.  Construct validity of the SEBQ could be 
investigated by comparison of SEBQ scores of participants with DB against MARM 
results. Once validation studies of the SEBQ have been performed, future studies 
may use the SEBQ as a clinical measure of the effects healthcare modalities have on 
the symptoms of DB.  The SEBQ may also be used in future for more clearly 
determining co-morbidities of DB. 
In order for the SEBQ to become a clinically applicable tool for the assessment of DB, 
normative values need to be established for classifying DB into categories such as 
mild, moderate, and severe DB.  A possible way to establish normative values of the 
SEBQ could be by testing the SEBQ on specific sample populations; for example 
testing a healthy group, a group with diagnosed DB, a group with medically 
unexplained dyspnea and a group with diagnosed cardiorespiratory disease and 
analysing the different scores.   
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The current study found a low level of variance amongst the lifestyle and 
demographic variables used as potential predictors of SEBQ score.  Further studies 
may investigate a wider range of potential predictors of SEBQ score and if more 
potential predictors can be identified this may allow for the development of clinical 
prediction rules for the prediction of SEBQ scores, and therefore dysfunctional 
breathers. 
6. Conclusions 
 
The Self Evaluation of Breathing Questionnaire has been shown to have high test-
retest reliability in a heterogeneous sample.  The presence of chronic respiratory 
disease, respiratory illness in the last two weeks and current smoking were 
independently associated with SEBQ scores. These three variables together with 
female gender may be predictors of SEBQ score and therefore dysfunctional 
breathing.  Further studies determining validity of the SEBQ are now warranted.  
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8. Tables 
 
Table 1. Participant characteristics at baseline 
 Female Male Total 
n 133 47 180 
SEBQ 16 ± 11 12 ± 8 15 ± 12 
BMI (kg/m2) 28 ± 8 30 ± 6 29 ±7 
Age (years) 39 ± 14 39 ± 16 39 ± 14 
Physical activity (MJ/week) 17 ± 17 22 ± 16 18 ± 16 
Frequency (%)    
  Smokers 21 13 19 
  Reported cardiovascular disease 10 17 12 
  Reported respiratory disease 28 26 27 
  Reported respiratory illness last 2 
weeks 25 24 24 
  Occupation Type     
      Active occupation 61 52 59 
      Sedentary occupation 31 39 33 
      Invalid/Retired 8 9 8 
Data are mean ± SD except for those reported as percentage of respondents. 
 
 
 
  
 
 
63 
 
Table 2. Mean SEBQ scores with presence or absence of lifestyle, demographic and 
health variables. 
Predictor Variables Present 
variable 
Absent 
variable 
P value 
   Respiratory disease 22 ± 4 13 ± 2 0.001 
   Current smoking 22 ± 5 14 ± 2 0.005 
   Current smoking without 
   respiratory problems*  
19 ± 6  10 ± 2 0.01 
   Acute respiratory infection 18 ± 4 14 ± 2 0.04 
   Cardiovascular disease 15 ± 5 16 ± 2 0.92 
   Female gender 16 ± 2 14 ± 4 0.54 
   Active occupation 16 ± 2 14 ± 3 0.47 
Data are mean ± 95% CI 
*  Respiratory problems include both respiratory disease and acute respiratory 
infection 
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 Table 3.  Correlations of continuous lifestyle, demographic 
and health variables with SEBQ. 
Predictor Variables Pearson’s r P value 
Age  -0.06 0.4 
BMI 0.12 0.1 
Physical activity 0.03 0.7 
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Table 4. Individual item analysis, ordered according to number of positive answers for each 
item.  
Item  n Positive 
answers 
Sum of 
scores 
Mean ± SD* 
I notice myself yawning (Q5) 162 253 17 ± 12 
I breathe through my mouth at night while I sleep (Q25) 139 247 17 ± 12 
I notice myself sighing (Q4) 129 177 18 ± 12 
I get easily breathless out of proportion to my fitness 
(Q1) 
126 172 19  ± 12 
I notice myself breathing shallowly (Q2) 116 153 20 ± 12 
I find myself breathing through my mouth during the day 
(Q24) 
107 188 19 ± 12 
I get breathless when I am anxious (Q11) 106 157 20 ± 12 
I feel I cannot get a deep or satisfying breath (Q6) 92 120 22 ± 12 
My breath feels like it does not go in all the way (Q18) 86 123 22 ± 12 
I feel breathless in association with other physical 
symptoms (Q13) 
84 108 22 ± 12 
I find myself holding my breath (Q12) 79 101 20 ± 12 
I notice that I am breathing irregularly (Q7) 77 102 24 ± 12 
I notice that I am breathing quickly (Q10) 76 88 23 ± 13 
My breathing feels stuck or restricted (Q8) 70 89 25 ± 12 
I feel that the air is stuffy, as if not enough air in the 
room (Q16) 
67 89 22 ± 13 
My breath feels like it does not go out all the way (Q19) 65 83 24 ± 12 
My breathing is heavy (Q20) 60 81 26 ± 12 
My breathing requires effort (Q23) 58 70 26 ± 12 
I feel that I am breathing more (Q21) 56 64 26 ± 12 
My breathing requires work (Q22) 55 71 26 ± 13 
My rib cage feels tight and can’t expand (Q9) 55 67 27 ± 12 
I have trouble coordinating my breathing when I am 
speaking (Q14) 
42 50 26 ± 14 
I can’t catch my breath (Q15) 40 49 27 ± 14 
I get short of breath reading and talking (Q3) 37 46 30 ± 14 
I get breathless even when I am resting (Q17) 23 29 31 ± 15 
*Average SEBQ ± SD for all participants who scored ≥ 1 on that item.  
Correlation coefficient (Mean SEBQ & sum of scores) r = -0.91 
Correlation coefficient (Mean SEBQ & N positive answers) r =-0.94 
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9. Figures 
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Figure 1. Test-retest reliability scatter plot. 
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Figure 2. Frequency distributions of SEBQ score in overall sample. 
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Figure 3. Frequency distributions of SEBQ score in asthmatic sample. 
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Appendix A: The Self Evaluation of Breathing Questionnaire 
(SEBQ) 
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The Self Evaluation of Breathing Questionnaire (SEBQ): Version 2 
 
Scoring this questionnaire: (0) never/not true at all; (1) occasionally/a bit true; (2) 
frequently/mostly true; and, (3) very frequently/very true 
 
1. I get easily breathless out of proportion to my fitness 
2. I notice myself breathing shallowly 
3. I get short of breath reading and talking 
4. I notice myself sighing 
5. I notice myself yawning 
6. I feel I cannot get a deep or satisfying breath 
7. I notice that I am breathing irregularly 
8. My breathing feels stuck or restricted 
9. My rib cage feels tight and can’t expand 
10. I notice that I am breathing quickly 
11. I get breathless when I am anxious 
12. I find myself holding my breath 
13. I feel breathless in association with other physical symptoms 
14. I have trouble coordinating my breathing when I am speaking 
15. I can’t catch my breath 
16. I feel that the air is stuffy, as if not enough air in the room 
17. I get breathless even when I am resting 
18. My breath feels like it does not go in all the way 
19. My breath feels like it does not go out all the way 
20. My breathing is heavy 
21. I feel that I am breathing more 
22. My breathing requires work 
23. My breathing requires effort 
24. I find myself breathing through my mouth during the day 
25. I breathe through my mouth at night while I sleep 
Resource: (Courtney & Greenwood, 2009)  
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analysis of method comparison studies. Statistician 1983; 32: 307-17. Bland JM, altman DG. Statistical 
methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-
10 
 
Ethics  
 
Work on human beings that is submitted to Physiotherapy should comply with the principles laid down in 
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including patients¿ images, names, initials, or hospital numbers, should not be included in videos, 
recordings, written descriptions, photographs, and pedigrees unless the information is essential for 
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form from the patient (or parent, guardian or next of kin where applicable). If such consent is made 
subject to any conditions, Elsevier must be made aware of all such conditions. Written consents must be 
provided to Elsevier on request. Even where consent has been given, identifying details should be 
omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in 
genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning 
and editors should so note. If such consent has not been obtained, personal details of patients included 
in any part of the paper and in any supplementary materials (including all illustrations and videos) must 
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Numbered style of referencing should be used. Authors should aim for 75% of their references to be 
within the preceding 5 years, with a limit of 40 references (5 references for case reports, 10 references 
for short communications, 20 references for technical reports). 
 
Citations in the text: Please ensure that every reference cited in the text is also present in the reference 
list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and 
personal communications should not be in the reference list, but may be mentioned in the text. Citation 
of a reference as 'in press' implies that the item has been accepted for publication. 
 
Citing and listing of web references. As a minimum, the full URL should be given. Any further 
information, if known (author names, dates, reference to a source publication, etc.), should also be given. 
Web references can be listed separately (e.g., after the reference list) under a different heading if 
desired, or can be included in the reference list; in square brackets in line with the text. 
 
Text: Indicate references by numbers in the text. The actual authors can be referred to, but the 
reference number(s) must always be given. 
 
List: Number the references in the list in the order in which they appear in the text. 
 
Examples: 
 
Reference to a journal publication: 
 
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 
2000;163:51-9. 
 
 
Reference to a book: 
 
[2] Strunk Jr W, White EB. The elements of style. 3rd ed. New York: Macmillan; 1979. 
 
 
Reference to a chapter in an edited book: 
 
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, 
editors. Introduction to the electronic age, New York: E-Publishing Inc; 1999, p. 281-304 
 
 
Note shortened form for last page number. e.g., 51-9, and that for more than 6 authors the first 6 should 
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Preparation of electronic illustrations Submitting your artwork in an electronic format helps us to 
produce your work to the best possible standards, ensuring accuracy, clarity and a high level of detail. 
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• Always supply high-quality printouts of your artwork, in case conversion of the electronic artwork is 
problematic. 
• Make sure you use uniform lettering and sizing of your original artwork. 
• Save text in illustrations as "graphics" or enclose the font.  
• Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol. 
• Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files, and supply a separate listing of the files and the 
software used. 
• Provide all illustrations as separate files and as hardcopy printouts on separate sheets. 
• Provide captions to illustrations separately. 
• Produce images near to the desired size of the printed version. 
• Produce figures at the approximate size of the publised version to ensure clarity 
 
 
A detailed guide on electronic artwork is available on our website:  http://www.elsevier.com/authors. 
 
Permission of borrowed illustrations or table or identifiable clinical photographs  
 
Permission to produce materials (illustrations and tables) must be obtained from the original publishers 
and authors, and submitted with the typescript. Borrowed material should be acknowledged in the 
captions in this style - 'Reproduced by kind permission of?(publishers) from?(reference)'. Written 
permission to use photographs of identifiable subjects must be provided. 
 
Colour illustrations  
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with 
the correct resolution. If, together with your accepted article, you submit usable colour figures then 
Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g., 
ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour 
in the printed version. For colour reproduction in print, you will receive information regarding the costs 
from Elsevier after receipt of your accepted article. Please indicate your preference for colour in print or 
on the Web only. For further information on the preparation of electronic artwork, please 
see  http://www.elsevier.com/artworkinstructions.  
 
Please note: Because of technical complications which can arise by converting colour figures to "grey 
scale" (for the printed version should you not opt for colour in print) please submit in addition usable 
black and white versions of all the colour illustrations.  
 
Captions  
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A 
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep 
text in the illustrations themselves to a minimum but explain all symbols and abbreviations useD. 
 
 
Line drawings  
The lettering and symbols, as well as other details, should have proportionate dimensions, so as not to 
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become illegible or unclear after possible reduction; in general, the figures should be designed for a 
reduction factor of two to three. The degree of reduction will be determined by the Publisher. Illustrations 
will not be enlarged. Consider the page format of the journal when designing the illustrations.  
 
Do not use any type of shading on computer-generated illustrations. 
 
Tables  
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables 
below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be 
sparing in the use of tables and ensure that the data presented in tables do not duplicate results 
described elsewhere in the article. 
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Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement'' (for more 
information on this and copyright see  http://www.elsevier.com/copyright). Acceptance of the 
agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent 
to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing 
Agreement' form or a link to the online version of this agreement. 
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from 
the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by 
authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 
239 3804, fax (+1) 215 239 3805, e-mail healthpermissions@elsevier.com. Requests may also be 
completed online via the Elsevier homepage (http://www.elsevier.com/locate/permissions).  
 
Funding body agreements and policies  
Elsevier has established agreements and developed policies to allow authors whose articles appear in 
journals published by Elsevier, to comply with potential manuscript archiving requirements as specified 
as conditions of their grant awards. To learn more about existing agreements and policies please 
visit  http://www.elsevier.com/fundingbodies  
 
Proofs  
 
One set of page proofs in PDF format will be sent by e-mail to the corresponding author (if we do not 
have an e-mail address then paper proofs will be sent by post). Elsevier now sends PDF proofs which 
can be annotated; for this you will need to download Adobe Reader version 7 available free 
from  http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF 
files will accompany the proofs. The exact system requirements are given at the Adobe site: 
http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win. 
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to 
the Query Form) and return to Elsevier in an e-mail. Please list your corrections quoting line number. If, 
for any reason, this is not possible, then mark the corrections and any other comments (including replies 
to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by 
post. 
Please use this proof only for checking the typesetting, editing, completeness and correctness of the 
text, tables and figures. Significant changes to the article as accepted for publication will only be 
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considered at this stage with permission from the Editor. We will do everything possible to get your 
article published quickly and accurately. Therefore, it is important to ensure that all of your corrections 
are sent back to us in one communication: please check carefully before replying, as inclusion of any 
subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that 
Elsevier may proceed with the publication of your article if no response is received. 
 
Offprints  
 
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. The PDF 
file is a watermarked version of the published article and includes a cover sheet with the journal cover 
image and a disclaimer outlining the terms and conditions of use. Additional paper offprints can be 
ordered by the authors. An order form with prices will be sent to the corresponding author.  
For further information please consult  http://www.elsevier.com/authors  
 
 
Submission checklist  
 
 
Ensure that the following items are present:  
 
 
• One author designated as corresponding author: 
• E-mail address 
• Full postal address 
• Telephone and fax numbers 
 
 
At the end of the paper, but before the references, please provide three statements: 
 
•Ethical Approval: The organisation providing ethical approval and ethics protocol reference number 
where appropriate. 
•Funding: any sources of funding should be stated. 
•Conflict of Interest: Disclosed conflicts will be published if they are believed to be important to readers 
in judging the manuscript. If there are no conflicts of interest, authors should state that there are none. 
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• References are in the Vancouver style 
• All references mentioned in the Reference list are cited in the text, and vice versa 
• Permission has been obtained for use of copyrighted material from other sources (including the Web) 
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Information for participants 
 
 
Test-Retest Reliability and Determinants of the Self 
Evaluation of Breathing Questionnaire (SEBQ): A Measure 
of Dysfunctional Breathing 
 
My name is Ashleigh Mitchell and I am currently in the fourth year of a program in Osteopathy 
at Unitec. Part of my Master of Osteopathy degree requires me to complete a research thesis 
on a subject of my choice. My research project is investigating the reliability and determinants 
the Self Evaluation of Breathing Questionnaire (SEBQ). Anyone over the age of 18 who can 
read and understand English, is not incapacitated or on bed rest for illness, and is not planning 
a major lifestyle change over the period of data collection of the study can participate in this 
study. This study has been approved by the Unitec Research Ethics Committee. 
What I am doing 
I want to find out if the measurements obtained by the SEBQ (Breathing Questionnaire) are 
reproducible if the questionnaire is repeated at different times. In addition, an aim of this study 
is to find out if there are any lifestyle or demographic factors associated with minor breathing 
dysfunction detected by this questionnaire. By taking part in this research project you will be 
helping me to determine these things. This study may help us gain a more comprehensive 
understanding about breathing problems which are estimated to affect many, otherwise healthy, 
people. If this study is shows that the questionnaire is reproducible, this questionnaire may be 
suitable for screening large numbers of people in health clinics internationally, to help identify 
dysfunctional breathing.  
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What it will mean for you 
If you choose to take part in this study, you will be asked to: 
 Provide your email address. 
 You will then be sent a link to the first questionnaire which will contain general questionnaire about 
yourself and your lifestyle, and the SEBQ (Breathing Questionnaire) which contains questions 
about how you breathe.  
 You will be asked to complete this questionnaire as soon as possible. Completion of the 
questionnaire should take you approximately five minutes each time. 
 12 days after this you will either receive an email with a link to the follow up questionnaire 
containing similar questions as previously and will be asked to fill it out on the same day of the 
week and approximately the same time of the day as the first. Completion of this should also take 
approximately five minutes. 
 You will receive reminders by email to complete the questionnaires at the required times. 
 If you agree to participate, and begin the questionnaire this will be taken as implied consent. This 
does not stop you from changing your mind if you wish to withdraw from the project. However, any 
withdrawals must be done within two weeks after you have completed your second questionnaire. 
Your name and any information that may identify you will be kept completely confidential. All 
information collected from you will be stored on a password protected file or locked filing cabinet 
and only you, my two supervisors and I (the primary researcher) will have access to this 
information.  
 
Please contact us if you need more information about the project or if at any time if you have any 
concerns about the research project you can contact my supervisor or I: 
My supervisor is Rob Moran email rmoran@unitec.ac.nz  
My phone number is 021 899 496 and email address is, SEBQresearch@gmail.com  
UREC REGISTRATION NUMBER: 2010-1089 
This study has been approved by the UNITEC Research Ethics Committee from (date) to (date).  
If you have any complaints or reservations about the ethical conduct of this research, you may 
contact the Committee through the UREC Secretary (ph: 09 815-4321 ext 6162.  Any issues you 
raise will be treated in confidence and investigated fully, and you will be informed of the 
outcome. 
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Appendix E: First (test) questionnaire 
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Appendix F: Second (retest) questionnaire 
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Appendix G: Figure representing bias of mean SEBQ scores 
between test and retest. 
 
  
 
 
108 
 
 
 
0 10 20 30 40 50 60 70
-30
-20
-10
0
10
20
mean
1 SD
2 SD
-1 SD
-2 SD
Mean SEBQ Score
C
h
a
n
g
e
 i
n
 S
E
B
Q
 S
c
o
re
 
Figure. Bias of mean SEBQ score between test and retest questionnaires. 
 
 
